A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer.
Saved in:
| Title: | A Phase 2 Trial of Protein Kinase C Iota Inhibition With the Combination of Auranofin and Sirolimus in Patients With Recurrent Ovarian Cancer. |
|---|---|
| Authors: | Jatoi A; Department of Oncology, Mayo Clinic, Rochester, MN., Foster NR; Department of Health Sciences Research, Section of Cancer Center Statistics, Mayo Clinic, Rochester, MN., Wahner Hendrickson A; Department of Oncology, Mayo Clinic, Rochester, MN., Block MS; Department of Oncology, Mayo Clinic, Rochester, MN., Weroha SJ; Department of Oncology, Mayo Clinic, Rochester, MN., Asmus EJ; Department of Health Sciences Research, Section of Cancer Center Statistics, Mayo Clinic, Rochester, MN., Murray NR; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL., Fields AP; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL. |
| Source: | American journal of clinical oncology [Am J Clin Oncol] 2026 May 01; Vol. 49 (5), pp. 238-242. Date of Electronic Publication: 2025 Oct 20. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1537-453X |
|---|---|
| DOI: | 10.1097/COC.0000000000001263 |
